Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.UK based BTG has received the US Food and Drug Administration (FDA) acceptance for reviewing biologics license application (BLA) of glucarpidase.
Subscribe to our email newsletter
Glucarpidase is an investigational product which is indicated for the rapid and sustained reduction of toxic methotrexate levels due to impaired renal function.
Additionally, the agency has granted priority review status for glucarpidase BLA.